{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_16", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "he maximum recommended \nhuman dose (MRHD) of 40 mg on a mg/m2 basis. Fetal body weight gain \nwas reduced, and skeletal ossification was delayed in both rats and \nrabbits at these doses; . . . \nFDA/CDER/OND/ODEIV/DPMH 20 \nExample: Old Labeling, continued \n8.1 Pregnancy \n \nNonteratogenic Effects \nNeonates exposed to [TRADENAME] and other SSRIs or serotonin and \nnorepinephrine reuptake inhibitors (SNRIs), late in the third trimester \nhave developed complications requiring prolonged hospitalization,"}